Americans say discussions about clinical trials should be part of standard of care

An overwhelming majority of Americans (86%) agree that health care professionals should discuss clinical trials with patients diagnosed with a disease as part of their standard of care, according to a new national public opinion survey commissioned by Research!America. And three-quarters of respondents (75%) agree that taking part in clinical trials is as valuable to our health care system as giving blood. But Americans are split on whether it's important for everyone to take part in a clinical trial if they are asked - 44% agree while 45% disagree and 12% are not sure. A higher percentage (74%) said they would participate if they are asked by someone they trust.

Eighty-percent of respondents say they have heard of a clinical trial, but only 18% say they or someone in their family has ever participated in one. More than half (55%) say individuals do not participate because of lack of awareness and information, followed by "too risky" (43%), lack of information about the process (41%), and lack of trust (38%). Nearly two-thirds (64%) say a doctor or health care provider is a reliable source for clinical trial information. Americans say doctors and other health care providers (44%), followed by the government (23%) have the greatest responsibility in educating the public about clinical trials, but a strong majority (74%) say neither their doctor nor other health care professional has ever talked to them about medical research.

A plurality of Americans (44%) agree that clinical trial participation should be a routine health behavior, whether healthy or ill, similar to getting an annual checkup with a health care provider. Men are significantly more likely to say participation should be routine (48%) than do women (39%). A larger percentage of 18 - 29 year olds (53%) and 30 -- 49 year olds (48%) agree compared to those 50 - 64 (38%) and 65 and above (34%).

The findings reveal a positive shift in public attitudes about clinical trials since a similar comprehensive survey was commissioned in 2013 by Research!America and partners. In the current survey, 37% of Americans say they would 'very likely' participate in a clinical trial if their doctor recommended, an 11% increase from 2013. Eighty-four percent are willing to share personal health information, assuming that appropriate privacy protections are in place, so researchers can better understand diseases and develop new ways to prevent, treat and cure them, a 10% increase, and 82% say they would share information to advance medical research, a 9% increase. When asked how much you admire people who volunteer for clinical trials, 46% said 'a great deal,' a 9% boost.

"More and more Americans appear to recognize the value of clinical trials - a very positive sign, but stubborn barriers to participation remain in place" said Mary Woolley, president and CEO of Research!America. "Development of incentives to drive more discussions between patients and health care professionals about the importance of participating in trials could encourage both ill and healthy individuals to view this as a routine health behavior." The results also indicate a willingness to tap into digital platforms for data sharing. A majority (72%) say they are likely to use technology such as apps, phones and monitoring devices to share their personal health data for clinical research. And nearly half (47%) say they like having clinical trial information/data/results delivered through their phone. A strong majority (88%) agree that participants should have access to results of clinical trials.

"We are pleased to have joined with Research!America in commissioning this important survey," said Doug Peddicord, executive director of the Association of Clinical Research Organizations (ACRO), "and gratified that the public's knowledge of and attitudes toward clinical trials have moved in positive directions since 2013. The option to participate in a clinical trial, when appropriate, should be a routine part of the health care encounter and ACRO will continue to work with Research!America and others to spread that message to doctors and patients alike."

The survey contains significant insights on factors important to clinical trial participation including competence and reputation of people or the institution conducting the research (91%); closely followed by opportunity to improve your own health and understanding potential risks and benefits (90%); whether you would have medical bills covered if you had an injury from the study (89%); the opportunity to improve the health of others (87%); having an expert guide you through the clinical trials process and the location of the clinical trial is easily accessible (86%).

Among other findings:

  • Ninety-percent agree that clinical trials are important to advancing science; and 87% agree clinical trials are important to improving our nation's health.
  • More than half (53%) say the federal government should provide tax incentives to companies to encourage them to conduct clinical trials in the U.S. rather than in other countries.
  • Nearly half (46%) say they are concerned that most medications approved by FDA for use in America are tested in other countries as well as in the U.S. - 38% say they are not concerned and 16% say they are not sure.

The nationwide survey of 1,000 U.S. adults was conducted by Zogby Analytics for Research!America and the Association of Clinical Research Organizations in July 2017. The margin of error is +/- 3.1 percentage points. To view the survey, click here.

About Research!America surveys
Research!America began commissioning surveys in 1992 in an effort to understand public support for medical, health and scientific research. The results of Research!America's surveys have proven invaluable to our alliance of member organizations and, in turn, to the fulfillment of our mission to make research to improve health a higher national priority. In response to growing usage and demand, Research!America has expanded its portfolio, which includes state, national and issue-specific polling.

About Research!America
Research!America is the nation's largest nonprofit public education and advocacy alliance working to make research to improve health a higher national priority. Founded in 1989, Research!America is supported by member organizations representing 125 million Americans.

Most Popular Now

Delivering insulin in a pill

Given the choice of taking a pill or injecting oneself with a needle, most of us would opt to regulate a chronic health condition by swallowing a pill. But for millions o...

Probiotics can protect the skeletons of older wome…

For the first time in the world, researchers at the University of Gothenburg, Sweden, have demonstrated that probiotics, dietary supplements with health-promoting bacteri...

Alzheimer's breakthrough: Brain metals that may dr…

Alzheimer's disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegen...

Can aspirin treat Alzheimer's?

A regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological r...

FDA approves first drug comprised of an active ing…

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms o...

In mice, stem cells seem to work in fighting obesi…

Obesity is an increasing global health problem associated with several comorbidities and a high risk of mortality. A wide spectrum of interventions has been proposed for ...

FDA takes steps to foster greater efficiency in bi…

Today, the agency withdrew the draft guidance, "Statistical Approaches to Evaluate Analytical Similarity," issued in September 2017. The draft guidance, if finalized as w...

Research shows how a moderate dose of alcohol prot…

For at least 20 years, research has shown that for many people, moderate consumption of alcohol can protect the heart, but the reason for this is poorly understood. A stu...

Some existing anti-cancer drugs may act in part by…

Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti...

'Kiss of death' cancer

It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negativ...

Novartis Clear about Psoriasis survey data highlig…

Novartis announced today the publication of global Clear about Psoriasis survey data in the Journal of the European Academy of Dermatology and Venereology[1]. The publica...

Poliovirus therapy for recurrent glioblastoma has …

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, wit...